News & Events
Chief Analytics Officer Slava Akmaev and Associate Director of Advanced Analytics Leo Rodrigues will kick off the “AI in Pharma Summit: Defining AI in Drug Discovery and Development” in Boston on Tuesday, Oct. 17. The pair will discuss “The Beginning of the AI Revolution in Pharma: Building a Pipeline by AI-Driven Discovery.” Learn more. […]
Slava Akmaev, BERG’s Chief Analytics Officer, speaks about artificial intelligence in biopharmaceutical research and development at The British Library in London on Sept. 14, 2017. The talk will focus on practical applications of Bayesian Artificial Intelligence in drug discovery and clinical development. The AI-informed discovery process provides an unbiased alternative approach to the more traditional[…]
The Wall Street Journal’s Daniela Hernandez talks to BERG about efforts to advance drug discovery through the use of AI. BERG’s Project Survival is featured as a key example of how we are working to improve the lives of patients through the use of AI technology. You can read the full article here: http://on.wsj.com/2u7QfmL
Slava Akmaev , Ph.D., Senior Vice President & Chief Analytics Officer at BERG Analytics will be speaking at the 2017 BioData World Conference in San Francisco. He will be discussing Supercomputing and the Future of Health: The use of AI in drug development How BERG uses artificial intelligence to analyze tissue samples and clinical data to model[…]
Slava Akmaev recently talked to Julian Upton at PharmaExec.com about the readiness of the biotech industry to adopt Big Data and analytics approaches to their work. You can view the article here: http://www.pharmexec.com/big-data-it-crunch-time-pharma?pageID=1
BERG Analytics will be exhibiting at HIMSS 17 , February 19th – 23rd at the Orange County Convention Center in Orlando Florida. Join us at booth #5584 and stop by to find out more about BERG Analytics’ bAIcis platform and our healthcare analytics solutions. http://www.himssconference.org/
HIT Consultant has published an article on BERG Analytics multi-year commercial agreement with Becton Dickinson to apply our AI platform bAIcis™ in order to provide deep analysis of the BD/MedMined hospital data with the objective of discovering new patterns and risk factors of patient medication non-compliance. The full article can be viewed here: http://hitconsultant.net/2017/01/12/bd-berg-health-partnership/
Non-obvious correlations to disease management unraveled by Bayesian artificial intelligence analyses of CMS data Artificial Intelligence in Medicine 2016, Vemulapalli et al. – bAIcis™, the Interrogative Biology® AI engine discovers a novel link between use of asthma medications and renal insufficiency Bayesian networks are powerful mathematical frameworks for learning probable cause and effect relationships from[…]
Real-time Clinical Predictions in a value based healthcare environment!
The healthcare industry is inundated with an ever expanding world of data from a multitude of diverse sources – from medication data to electronic health records (EHRs) to claim transactions. While this overwhelming amount of data can be a challenge it also represents an opportunity to gain unparalleled intelligence from your own data to drive better patient outcomes and lower operational costs! BERG Analytics can develop a data and analytics driven solution from your own resources to move your organization forward in the new healthcare landscape. BERG Analytics’ Patient Intelligence Platform will allow you to leverage your data to gain a competitive edge by improving the health of your patient populations as you reduce the overall per capita costs of delivering quality healthcare.
Diverse data sources
New insights into clinical and financial outcomes
The most effective treatments for each patient
High value care
A patient intelligence™ platform
Turning your data into Patient Intelligence™!
The bAIcis™ Solution platform allows our clients to harness the full power of Prescriptive and Predictive Analytics by applying a unique blend of evidence based science, big data integration, machine learning technology, and proprietary algorithms.
With bAIcis™, patients are empowered to understand more about their health. Practitioners, researchers, and insurers can confidently use the actionable intelligence from bAIcis™ to make better, faster, and more impactful decisions!